Compare KDP & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KDP | GEHC |
|---|---|---|
| Founded | 1981 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Computer Software: Prepackaged Software |
| Sector | Consumer Staples | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.4B | 38.9B |
| IPO Year | 1993 | N/A |
| Metric | KDP | GEHC |
|---|---|---|
| Price | $27.28 | $79.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 12 |
| Target Price | $35.06 | ★ $88.75 |
| AVG Volume (30 Days) | ★ 10.8M | 3.4M |
| Earning Date | 02-24-2026 | 02-04-2026 |
| Dividend Yield | ★ 3.35% | 0.18% |
| EPS Growth | N/A | ★ 32.35 |
| EPS | 1.16 | ★ 4.83 |
| Revenue | $16,174,000,000.00 | ★ $20,246,000,000.00 |
| Revenue This Year | $8.10 | $6.42 |
| Revenue Next Year | $4.78 | $4.34 |
| P/E Ratio | $23.70 | ★ $16.35 |
| Revenue Growth | ★ 6.77 | 3.51 |
| 52 Week Low | $25.03 | $57.65 |
| 52 Week High | $36.12 | $94.80 |
| Indicator | KDP | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 45.47 | 41.54 |
| Support Level | $26.40 | $77.67 |
| Resistance Level | $27.76 | $83.21 |
| Average True Range (ATR) | 0.59 | 1.75 |
| MACD | -0.04 | -0.54 |
| Stochastic Oscillator | 46.55 | 15.31 |
Keurig Dr Pepper was established in 2018 following a merger between Keurig Green Mountain Coffee and Dr Pepper Snapple. The company manufactures and distributes coffee systems (including coffee brewers and single-serve coffee pods) under the Keurig and Green Mountain brands, as well as ready-to-drink beverages including flavored (non-cola) sparkling soft drinks under well-known brands such as Dr Pepper, Snapple, and Canada Dry. The company controls production and route to market for its own brands through in-house manufacturing plants and distribution infrastructure and leverages these facilities to manufacture and distribute for third-party coffee and beverage brands via licensing and partnership agreements. The US and Canada make up 95% of revenue, with the rest from Mexico.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).